Goldstein, and H
Youve been diagnosed with multiple endocrine neoplasia syndrome type 2 (MEN 2) : This rare genetic condition predisposes individuals to certain cancers, including MTC
However, realizing broader societal impact requires addressing fundamental cost, access, and long-term sustainability challenges
The post which was published last August 13, 2024, has already accumulated 14,000 reactions, 756 comments, 743 shares, and 3.4 million views, as of writing
PF-06882961 was a partial agonist in recruiting Arr2 (EC 50 = 490 nM, E max = 36%), while exenatide (Arr2 EC 50 = 9.0 nM, E max = 75%) and liraglutide (Arr2 EC 50 = 20 nM, E max = 99%) were respectively 54- and 23-fold more potent with greater E max values